BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12114885)

  • 21. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
    Jacques PF; Kalmbach R; Bagley PJ; Russo GT; Rogers G; Wilson PW; Rosenberg IH; Selhub J
    J Nutr; 2002 Feb; 132(2):283-8. PubMed ID: 11823591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin B-12 status is inversely associated with plasma homocysteine in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms.
    Bailey LB; Duhaney RL; Maneval DR; Kauwell GP; Quinlivan EP; Davis SR; Cuadras A; Hutson AD; Gregory JF
    J Nutr; 2002 Jul; 132(7):1872-8. PubMed ID: 12097662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.
    Mijatovic V; Kenemans P; Jakobs C; van Baal WM; Peters-Muller ER; van der Mooren MJ
    Obstet Gynecol; 1998 Mar; 91(3):432-6. PubMed ID: 9491873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women.
    Cagnacci A; Generali M; Pirillo D; Baldassari F; Volpe A
    Climacteric; 2006 Oct; 9(5):388-95. PubMed ID: 17000586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
    Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
    Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
    Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of hormone replacement therapy on homocysteine and echocardiography in postmenopausal women].
    Hui Y; Wu Y; Xiao L; Tang Z; Wu Y; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):598-600. PubMed ID: 12487933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the relationship between methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine level in pregnancy induced hypertension patients].
    Li K; Sun Y; Chen L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):205-7. PubMed ID: 11776159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome.
    Orio F; Palomba S; Di Biase S; Colao A; Tauchmanova L; Savastano S; Labella D; Russo T; Zullo F; Lombardi G
    J Clin Endocrinol Metab; 2003 Feb; 88(2):673-9. PubMed ID: 12574198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study.
    van Hoof HJ; van der Mooren MJ; Swinkels LM; Sweep CG; Merkus JM; Benraad TJ
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):511-6. PubMed ID: 10468912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
    Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
    Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.
    Andreassi MG; Botto N; Cocci F; Battaglia D; Antonioli E; Masetti S; Manfredi S; Colombo MG; Biagini A; Clerico A
    Hum Genet; 2003 Feb; 112(2):171-7. PubMed ID: 12522558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
    Blankenberg S; Rupprecht HJ; Peetz D; Bickel C; Hofman KP; Tiret L; Meyer J
    Dtsch Med Wochenschr; 2002 Apr; 127(14):729-35. PubMed ID: 11935469
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study.
    Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR
    Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and plasma homocysteine levels.
    van Baal WM; Smolders RG; van der Mooren MJ; Teerlink T; Kenemans P
    Obstet Gynecol; 1999 Oct; 94(4):485-91. PubMed ID: 10511346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.
    Fijnheer R; Roest M; Haas FJ; De Groot PG; Derksen RH
    J Rheumatol; 1998 Sep; 25(9):1737-42. PubMed ID: 9733454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.